Biosimilars for Retinal Diseases: Understanding the Phase 3 Clinical Trial Design
Ashish Sharma, Baruch D. Kuppermann
Topics & Concepts
BiosimilarMedicineRanibizumabClinical trialMacular degenerationAfliberceptOphthalmologyScopusRandomized controlled trialInternal medicineMEDLINEBevacizumabLawPolitical scienceChemotherapyRetinal Diseases and TreatmentsRetinal and Optic ConditionsSystemic Lupus Erythematosus Research